Sketch of an approach to use AI for identifying hidden (ultra-)rare disease patients in national healthcare records.

Proudly received a certificate by MIT Sloan School of Manmagement on “Artificial Intelligence: Implications for Business Strategy”.

Fireside chat at Dec 2025 AMCX monthly meeting on transforming customer interactions and relationships by digitizing the journey.

Dr. Christian Velten speaking at MedFIT 2025 conference, about “The empowerment of the people: digital health, self-care and the future of healthcare”.

AI is increasingly competing with pharma and healthcare industries on information and knowlegde about their products. This should not be ignored anymore.

In today’s dynamic political landscape, European pharmaceutical companies have a unique opportunity to thrive despite the challenges presented by evolving US policies. While tariffs and cost pressures may cause hesitation, this moment calls for innovation and bold strategies. Are these obstacles a chance for growth, or merely an excuse to hold back?